Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. engages in the research and development, production, and sale of new pharmaceutical excipients in China. The co...
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-Rez
SUNHERE released its performance for the first three quarters, with a net profit attributable to the parent company of 133 million yuan, an increase of 8.28%
SUNHERE: The controlling shareholder and actual controller has changed from Yin Zhenglong to Wu Changhong
SUNHERE released its performance for the first half of the year, with a net profit attributable to the parent company of 93.0352 million yuan, a decrease of 2.61%
SUNHERE has added 1 new pharmaceutical excipient product
The chemical pharmaceutical sector continues to rise, with SUNHERE and Lionco hitting the daily limit